We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
The International Journal of Oral & Maxillofacial Implants



Forgotten password?


Int J Oral Maxillofac Implants 23 (2008), No. 6     15. Nov. 2008
Int J Oral Maxillofac Implants 23 (2008), No. 6  (15.11.2008)

Page 1071-1081, PubMed:19216276

Factors Influencing Effects of Specific COX-2 Inhibitor NSAIDs on Growth and Differentiation of Mouse Osteoblasts on Titanium Surfaces
Arpornmaeklong, Premijt / Akarawatcharangura, Butsakorn / Pripatnanont, Prisana
Purpose: To investigate the influence of exposure time and stages of cell growth on the effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of osteoblasts on smooth titanium surfaces. Materials and Methods: The study was categorized into 5 groups: group A, 0.1 µM indomethacin; group B, 1.5 µM celecoxib; group C, 3.0 µM celecoxib; group D, 9.0 µM celecoxib; and group E, serum-free culture medium without drug treatment. A mouse calvarial cell line, MC3T3-E1, was seeded on acid-prickled surface titanium disks. The investigations were performed in 3 experimental phases based on stages of cell growth: static (24 hours after seeding), log (culture day 5), and plateau (culture day 12). In each experimental phase, cells on titanium disks were incubated in a medium treated with drugs according to the groups of study for 1, 3, and 5 days. Results: Indomethacin and celecoxib in groups A to D inhibited growth of cells on treatment days 3 and 5 in static phase and on treatment day 3 in log phase. Additionally, an inhibitory effect of indomethacin was greater than celecoxib. Effects on alkaline phosphatase (ALP) activity and osteocalcin were not clearly demonstrated. A significant decrease of PGE2 production was found in groups A to D in static and plateau but not log phases. Conclusion: A specific COX-2 inhibitor NSAID, celecoxib, inhibited growth of osteoblasts on titanium surfaces and the effects were influenced by exposure time and stages of cell growth. Using a specific COX-2 inhibitor might cause deterioration of osteointegration of dental implants by interfering with osteoblastic cell growth in the proliferative stage.

Keywords: growth and differentiation, osteoblasts, specific COX-2 inhibitor NSAIDs, titanium surface